Global Artificial Pancreas Devices Systems Market Growth 2024-2030

Publication ID:

LPI01240455

Publication Date:

January 4, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period.
The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Pancreas Devices Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Pancreas Devices Systems market.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
Key Features:
The report on Artificial Pancreas Devices Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Pancreas Devices Systems market. It may include historical data, market segmentation by Type (e.g., Threshold Suspended Device Systems, Hybrid Closed-loop APDS), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Pancreas Devices Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Pancreas Devices Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Pancreas Devices Systems industry. This include advancements in Artificial Pancreas Devices Systems technology, Artificial Pancreas Devices Systems new entrants, Artificial Pancreas Devices Systems new investment, and other innovations that are shaping the future of Artificial Pancreas Devices Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Pancreas Devices Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Pancreas Devices Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Pancreas Devices Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Pancreas Devices Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Pancreas Devices Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Pancreas Devices Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Pancreas Devices Systems market.
Market Segmentation:
Artificial Pancreas Devices Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Pancreas Devices Systems market?
What factors are driving Artificial Pancreas Devices Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Pancreas Devices Systems market opportunities vary by end market size?
How does Artificial Pancreas Devices Systems break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Pancreas Devices Systems Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Artificial Pancreas Devices Systems by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Artificial Pancreas Devices Systems by Country/Region, 2019, 2023 & 2030
2.2 Artificial Pancreas Devices Systems Segment by Type
2.2.1 Threshold Suspended Device Systems
2.2.2 Hybrid Closed-loop APDS
2.2.3 Other Systems
2.3 Artificial Pancreas Devices Systems Sales by Type
2.3.1 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2019-2024)
2.3.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Type (2019-2024)
2.3.3 Global Artificial Pancreas Devices Systems Sale Price by Type (2019-2024)
2.4 Artificial Pancreas Devices Systems Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Artificial Pancreas Devices Systems Sales by Application
2.5.1 Global Artificial Pancreas Devices Systems Sale Market Share by Application (2019-2024)
2.5.2 Global Artificial Pancreas Devices Systems Revenue and Market Share by Application (2019-2024)
2.5.3 Global Artificial Pancreas Devices Systems Sale Price by Application (2019-2024)
3 Global Artificial Pancreas Devices Systems by Company
3.1 Global Artificial Pancreas Devices Systems Breakdown Data by Company
3.1.1 Global Artificial Pancreas Devices Systems Annual Sales by Company (2019-2024)
3.1.2 Global Artificial Pancreas Devices Systems Sales Market Share by Company (2019-2024)
3.2 Global Artificial Pancreas Devices Systems Annual Revenue by Company (2019-2024)
3.2.1 Global Artificial Pancreas Devices Systems Revenue by Company (2019-2024)
3.2.2 Global Artificial Pancreas Devices Systems Revenue Market Share by Company (2019-2024)
3.3 Global Artificial Pancreas Devices Systems Sale Price by Company
3.4 Key Manufacturers Artificial Pancreas Devices Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Pancreas Devices Systems Product Location Distribution
3.4.2 Players Artificial Pancreas Devices Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artificial Pancreas Devices Systems by Geographic Region
4.1 World Historic Artificial Pancreas Devices Systems Market Size by Geographic Region (2019-2024)
4.1.1 Global Artificial Pancreas Devices Systems Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Artificial Pancreas Devices Systems Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Artificial Pancreas Devices Systems Market Size by Country/Region (2019-2024)
4.2.1 Global Artificial Pancreas Devices Systems Annual Sales by Country/Region (2019-2024)
4.2.2 Global Artificial Pancreas Devices Systems Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artificial Pancreas Devices Systems Sales Growth
4.4 APAC Artificial Pancreas Devices Systems Sales Growth
4.5 Europe Artificial Pancreas Devices Systems Sales Growth
4.6 Middle East & Africa Artificial Pancreas Devices Systems Sales Growth
5 Americas
5.1 Americas Artificial Pancreas Devices Systems Sales by Country
5.1.1 Americas Artificial Pancreas Devices Systems Sales by Country (2019-2024)
5.1.2 Americas Artificial Pancreas Devices Systems Revenue by Country (2019-2024)
5.2 Americas Artificial Pancreas Devices Systems Sales by Type
5.3 Americas Artificial Pancreas Devices Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Pancreas Devices Systems Sales by Region
6.1.1 APAC Artificial Pancreas Devices Systems Sales by Region (2019-2024)
6.1.2 APAC Artificial Pancreas Devices Systems Revenue by Region (2019-2024)
6.2 APAC Artificial Pancreas Devices Systems Sales by Type
6.3 APAC Artificial Pancreas Devices Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artificial Pancreas Devices Systems by Country
7.1.1 Europe Artificial Pancreas Devices Systems Sales by Country (2019-2024)
7.1.2 Europe Artificial Pancreas Devices Systems Revenue by Country (2019-2024)
7.2 Europe Artificial Pancreas Devices Systems Sales by Type
7.3 Europe Artificial Pancreas Devices Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Pancreas Devices Systems by Country
8.1.1 Middle East & Africa Artificial Pancreas Devices Systems Sales by Country (2019-2024)
8.1.2 Middle East & Africa Artificial Pancreas Devices Systems Revenue by Country (2019-2024)
8.2 Middle East & Africa Artificial Pancreas Devices Systems Sales by Type
8.3 Middle East & Africa Artificial Pancreas Devices Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Pancreas Devices Systems
10.3 Manufacturing Process Analysis of Artificial Pancreas Devices Systems
10.4 Industry Chain Structure of Artificial Pancreas Devices Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Pancreas Devices Systems Distributors
11.3 Artificial Pancreas Devices Systems Customer
12 World Forecast Review for Artificial Pancreas Devices Systems by Geographic Region
12.1 Global Artificial Pancreas Devices Systems Market Size Forecast by Region
12.1.1 Global Artificial Pancreas Devices Systems Forecast by Region (2025-2030)
12.1.2 Global Artificial Pancreas Devices Systems Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Pancreas Devices Systems Forecast by Type
12.7 Global Artificial Pancreas Devices Systems Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Bigfoot Biomedical
13.2.1 Bigfoot Biomedical Company Information
13.2.2 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bigfoot Biomedical Main Business Overview
13.2.5 Bigfoot Biomedical Latest Developments
13.3 Beta Bionics
13.3.1 Beta Bionics Company Information
13.3.2 Beta Bionics Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Beta Bionics Main Business Overview
13.3.5 Beta Bionics Latest Developments
13.4 Admetsys
13.4.1 Admetsys Company Information
13.4.2 Admetsys Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Admetsys Main Business Overview
13.4.5 Admetsys Latest Developments
13.5 Insulet
13.5.1 Insulet Company Information
13.5.2 Insulet Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.5.3 Insulet Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Insulet Main Business Overview
13.5.5 Insulet Latest Developments
13.6 Tandem Diabetes Care
13.6.1 Tandem Diabetes Care Company Information
13.6.2 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Tandem Diabetes Care Main Business Overview
13.6.5 Tandem Diabetes Care Latest Developments
13.7 Defymed
13.7.1 Defymed Company Information
13.7.2 Defymed Artificial Pancreas Devices Systems Product Portfolios and Specifications
13.7.3 Defymed Artificial Pancreas Devices Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Defymed Main Business Overview
13.7.5 Defymed Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂